Alembic Pharmaceuticals planning to raise Rs 350 crore via NCDs

10 Dec 2018 Evaluate

Alembic Pharmaceuticals is planning to the issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 350 crore on Private Placement Basis. The meeting of the NCD Committee of the company will be held on December 14, 2018, inter-alia to consider and approve the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

961.30 -8.35 (-0.86%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.